Did you know?

Last Updated: 24-Oct-2022. Syncona Limited, a leading healthcare company focused on founding, building and funding global leaders in life science, today announces that its …APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or ...Applied Genetic Technologies is not a large company by global standards. It has a market capitalization of US$122m, which means it wouldn't have the attention of many institutional investors.Syncona to Acquire Applied Genetic Technologies Corporation. Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s closing stock price on ...Applied Genetic Technologies Corporation T: (617) 843-5728 [email protected]. Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754Syncona Limited, a leading healthcare company focused on founding, building and funding global leaders in life science, today announces that its newly established portfolio company has agreed to acquire, by a tender offer, all outstanding shares of Applied Genetic Technologies Corporation ("AGTC") (Nasdaq: AGTC), a clinical-stage biotechnology ...Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan Lieber Chief Financial ...Oct 24, 2022 · These now include Applied Genetic Technologies Corp., which, rather than face the “challenging” funding environment ahead, has opted for a $23.5 million sale to investment fund Syncona. AGTC ... Indici APPLIED GENETIC TECHNOLOGIES CORPORATION: profilo societario, assetto del gruppo, attività e posizione competitiva e informazioni sul capitale.Apple is a technology company that sells consumer electronics. The multinational corporation designs and develops products that range from home computers to personal devices. The serial number on your Apple device is important as it helps t...Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected]. Corporate Contact: Jonathan LieberApplied Genetic Technologies Company Info. Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope ...Applied Genetic Technologies Corporation . 14193 NW 119 th Terrace, Suite 10 . Alachua, Florida 32615 (386) 462-2204 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications . on Behalf of the Person(s) Filing Statement) With copies to:Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated rAAV2tYF-GRK1-hRPGRco, to treat X-linked retinitis pigmentosa (XLRP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene.Oct 24, 2022 · Applied Genetic Technologies Corporation Contacts: IR Contact: David Carey Lazar FINN Partners T: (212) 867-1768 [email protected] Corporate Contact: Jonathan Lieber Chief Financial Officer Applied Genetic Technologies Corporation T: (617) 843-5778 [email protected] GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage... March 21, 2022 16:01 ET | Source: Applied ...NEW YORK, GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 24Oct 24, 2022 · Applied Genetic Technologies Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing. The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with … This presentation contains forward-looking statements that refl Applied Genetic Technologies Corporation. One Kendall Square, 1400W. Cambridge, MA 02139 . Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or … GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 09, 2020

Gift giving is a happy event, but it might be especially tricky when the etiquette and expectations of the professional world apply. Whether you’re giving corporate gifts to employees or looking for small business client gift ideas, these o...APPLIED GENETIC TECHNOLOGIES CORPORATION: BALANCE SHEETS (Unaudited) September 30, June 30, In thousands, except per share data 2020 …Applied Genetic Technologies Corporation T: (617) 413-2754 [email protected] ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a ...GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful ...May 13, 2021 · GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno ... October 24, 2022. Venture firm Syncona is acquiring Applied Genetic Technologies Corporation, a company focused on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, for approximately $23.5 million plus ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 23, 2022 . Possible cause: Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associat.